We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The World Health Organisation (WHO) will seek support for a system to keep track of clinical trials at its Ministerial Summit on Health Research in Mexico next week (16-20 November). The system would form an Internet-based means of accessing registers of clinical trials around the world. The WHO also wants to create a system allowing individual trials to be identified and tracked.

The system has been proposed as a way of reducing the duplication of trials. Researchers and patient advocates have been lobbying for a global register as a means of bringing more information about clinical trails — especially those undertaken by pharmaceutical companies — into the public domain. The WHO would establish minimum standards on what information to include in the each registry.

Registries of clinical trials are starting to garner support after recent scandals about important unpublished data about safety of antidepressants that were already on the market. Financing hurdles might make it difficult for clinical trial data from developing countries to be incorporated into a global system.

Link to full Nature news story

Related topics